AngioChem's Unattributed VC Round

AngioChem raised a round of funding on December 12, 2005.

AngioChem is a clinical-stage biotechnology discovering and developing new breakthrough drugs that are capable of crossing the blood-brain barrier to treat brain diseases. The company's EPiC platform …

Articles about AngioChem's Unattributed VC Round: